Palmetto Clinical Trial Services, LLC

Greenville, South Carolina 29615

2 studies enrolling now · 15 studies all time

What they study most

Acne, Acne Vulgaris, Actinic Keratosis, Acute Gout, Arthritis, Rheumatoid, Onychomycosis, Osteoarthritis, Hip, Osteoarthritis, Knee, Plaque Psoriasis, Psoriasis, Rheumatoid Arthritis, Rosacea

Studies at this site

• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities — Recruiting now
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp — Recruiting now
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) — Running, not enrolling
• Dose Range Study of CD5789 in Acne Vulgaris — Completed
• Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• Epiduo Pediatric Acne Study — Completed
• Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris — Completed
• Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate — Completed
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients — Completed
• Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis — Completed